ConductScience.org, home

Gene · 1364

Papers3,919

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

121 to 140 of 3,919

Download this page as JSON
TitleJournalYearPMIDFound bySource
Role of homovanillic acid esters in the regulation of skin inflammatory pathways and their effect on tight junction protein expression.Front Pharmacol202540761393PubTator, text miningPubMed
SMARCB1/INI1-deficient lung cancer with lymph node metastasis: a case report and literature review.AME Case Rep202540761191PubTator, text miningPubMed
Integrated multi-omics and machine learning reveal an immunogenic cell death-related signature for prognostic stratification and therapeutic optimization in colorectal cancer.Front Immunol202540740776PubTator, text miningPubMed
Mechanism Study on Inhibition of EPHA2 Expression Impaired Skin Barrier Function by Gefitinib.Exp Dermatol202540734331PubTator, text miningPubMed
PYGO1 drives gastric cancer progression via the ITGB1/CD47 axis and is therapeutically targeted by pentagalloylglucose.J Transl Med202540731404PubTator, text miningPubMed
The effect of Hydrocortisone on implantation through upregulation of tight junction genes: A lab trial study.JBRA Assist Reprod202540674556PubTator, text miningPubMed
Metastatic SMARCA4-Deficient Undifferentiated Carcinoma of the Oral Cavity: A Case Report and Review of Literature.Head Neck Pathol202540658292PubTator, text miningPubMed
[Malignant peritoneal mesothelioma detected by endoscopy after intractable stuttering:a case report].Nihon Shokakibyo Gakkai Zasshi202540634079PubTator, text miningPubMed
CLDN4 palmitoylation promotes hepatic-to-biliary lineage transition and lenvatinib resistance in hepatocellular carcinoma.Cell Rep Med202540592346PubTator, text miningPubMed
Key mediators of the efficacy of mesenchymal stem cells on in vivo disease models.Cell Transplant202540560652PubTator, text miningPubMed
Human milk metabolites modulate gut barrier and immunity-related genes in an in vitro multicellular model of intestinal epithelium.Food Funct202540538378PubTator, text miningPubMed
[Another sight at Gastric Cancer Molecular Classification: novel subtypes based on expression of CDX-2, E-cadherin, Epstein-Barr virus RNAs, MMR proteins].Arkh Patol202540531557PubTator, text miningPubMed
Integrative Machine Learning and Bioinformatics Approach for Identifying Key Biomarkers in Gallbladder Cancer Diagnosis and Progression.IET Syst Biol202540527859PubTator, text miningPubMed
Evaluation of the Role of Claudin-4 Antigen Overexpression in Triple-Negative Breast Cancer Patients: A 5-Year Survival Analysis.Iran J Pathol202540487255PubTator, text miningPubMed
Adverse effects of a realistic concentration of human exposure to microplastics on markers of placental barrier permeability in pregnant rats.Environ Sci Pollut Res Int202540445558PubTator, text miningPubMed
The green tea component (-)-epigallocatechin-3-gallate protects against cytokine-induced epithelial barrier damage in intestinal epithelial cells.Front Pharmacol202540438590PubTator, text miningPubMed
S100A4 participates in sepsis-induced endothelial cell inflammatory response and barrier damage by binding to BRD4.Clin Hemorheol Microcirc202540433870PubTator, text miningPubMed
p38 MAPK-mediated upregulation of claudin-3 and claudin-4 by gemcitabine contributes to chemoresistance in ovarian cancer.Int J Biochem Cell Biol202540403836PubTator, text miningPubMed
SMARCA4 deficiency: implications for non-small cell lung cancer and management strategies, with relevance to and distinctions from thoracic undifferentiated tumor.Transl Lung Cancer Res202540386720PubTator, text miningPubMed
Integration of Multi-Omics and Network Pharmacology Analysis Reveals the Mechanism of Qingchang Huashi Jianpi Bushen Formula in Repairing the Epithelial Barrier of Ulcerative Colitis.J Inflamm Res202540386180PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/1364/papers?page=7